Column

Clinical Pathways GPS

Virtual Health Care: Advances, Coverage, and Use

04/22/2021

Empowered consumers, increasingly interoperable data, and scientific and technological advances are transforming the health care system we know today. Virtual health has the capacity to inform, personalize,...

...

04/22/2021

Journal of Clinical Pathways

Pharma Insights

Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond

04/22/2021

Andrew Cournoyer , RPh, MBA;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

The continued rise in health care spending continues to have a profound effect on the US economy and health care payers. The three complex drivers contributing to these increases include hospital, outpatient, and...

The...

04/22/2021

Journal of Clinical Pathways

COA Viewpoint

How Community Oncology Can Optimize COVID-19 Vaccine Administration

03/16/2021

Frederick M. Schnell , MD, FACP;

Recently, the Community Oncology Alliance Board of Directors submitted a letter to all 50 US governors to urge that local, independent oncology practices be given priority approval to administer COVID-19 vaccinations...

...

03/16/2021

Journal of Clinical Pathways

COA Viewpoint

Meeting the Challenges of Community Oncology at the Virtual #COA2021

02/22/2021

Fred Divers , MD;

While the rollercoaster ride of 2020 is now over, the repercussions from events over those months will persist into 2021, creating new challenges for community oncology. How will practices adapt to the influx of new...

While...

02/22/2021

Journal of Clinical Pathways

Editor's Page

Advancing Technologies for Clinician Decision Support

12/16/2020

Winston Wong , PharmD;

The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...

The...

12/16/2020

Journal of Clinical Pathways

Clinical Pathways GPS

Digital Health Placement in Clinical Pathways

12/16/2020

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Martin Culjat , PhD;

Brian C. Abraham , MPA;

The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...

The...

12/16/2020

Journal of Clinical Pathways

COA Viewpoint

Preliminary Comment Letter on Most Favored Nation Experiment and Impact on Older Adults With Cancer

12/16/2020

Nicolas Ferreyros ;

Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...

...

12/16/2020

Journal of Clinical Pathways

Trending From ACCC

Concerns About the Real-World Impact of CMS’ Radiation Oncology Model

12/16/2020

Association of Community Cancer Centers

While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...

While...

12/16/2020

Journal of Clinical Pathways

Pharma Insights

Does COVID-19 Threaten the Progress Pharmaceuticals Have Made in Reducing Cancer Mortality Over the Last 20 Years?

12/16/2020

Farzad Ali , BPharm, MS;

Joanna P. MacEwan , PhD;

Jason Shafrin , PhD;

The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...

The...

12/16/2020

Journal of Clinical Pathways

Editor's Page

When Data, Technology, and Art Converge

11/18/2020

Winston Wong , PharmD;

Disease, clinical research, pathology, drugs, treatment guidelines and protocols, diagnostic tests and procedure, regulations, reimbursement—these are everyday elements of the average physician, and they are...

...

11/18/2020

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products